| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
234,479 |
223,340 |
$56.35M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
258,134 |
245,986 |
$46.50M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
126,913 |
119,346 |
$17.15M |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
36,516 |
35,232 |
$10.93M |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
75,575 |
72,613 |
$9.38M |
| 90378 |
|
2,114 |
2,002 |
$7.00M |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
152,850 |
122,296 |
$6.99M |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
80,814 |
76,897 |
$6.67M |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
100,521 |
85,049 |
$5.93M |
| 70450 |
Computed tomography, head or brain; without contrast material |
31,364 |
29,838 |
$5.00M |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
10,854 |
10,730 |
$4.52M |
| G0378 |
Hospital observation service, per hour |
8,967 |
8,414 |
$4.49M |
| D2930 |
Prefabricated stainless steel crown - primary tooth |
24,723 |
4,681 |
$3.64M |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
92,938 |
85,461 |
$3.55M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
28,026 |
26,731 |
$3.40M |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
398,618 |
355,715 |
$3.03M |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
62,538 |
57,276 |
$3.00M |
| 96375 |
Therapeutic injection; each additional sequential IV push |
61,066 |
52,234 |
$2.97M |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
63,910 |
28,168 |
$2.84M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
35,996 |
33,384 |
$2.78M |
| 71046 |
Radiologic examination, chest; 2 views |
55,444 |
52,571 |
$2.73M |
| 80048 |
Basic metabolic panel (calcium, ionized) |
251,918 |
224,597 |
$2.38M |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
67,995 |
65,949 |
$2.36M |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
68,009 |
65,963 |
$2.34M |
| 47562 |
|
805 |
791 |
$2.33M |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
7,775 |
7,558 |
$2.20M |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
4,658 |
4,604 |
$2.20M |
| 95810 |
Polysomnography; sleep staging with 4 or more additional parameters |
2,736 |
2,708 |
$2.10M |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
45,837 |
34,259 |
$1.98M |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
19,728 |
16,148 |
$1.92M |
| 84443 |
Thyroid stimulating hormone (TSH) |
125,867 |
122,002 |
$1.90M |
| 80053 |
Comprehensive metabolic panel |
186,402 |
170,852 |
$1.87M |
| 81513 |
|
13,812 |
13,466 |
$1.73M |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
8,410 |
8,131 |
$1.66M |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
13,611 |
10,880 |
$1.65M |
| 93976 |
|
11,308 |
10,831 |
$1.57M |
| J1561 |
Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg |
931 |
365 |
$1.56M |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
3,681 |
3,608 |
$1.52M |
| 87631 |
|
11,451 |
11,199 |
$1.49M |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
15,544 |
15,055 |
$1.46M |
| D2934 |
|
10,173 |
2,752 |
$1.46M |
| 96361 |
Intravenous infusion, hydration; each additional hour |
41,339 |
36,457 |
$1.45M |
| 90791 |
Psychiatric diagnostic evaluation |
12,624 |
11,620 |
$1.45M |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
13,696 |
13,058 |
$1.39M |
| 72125 |
Computed tomography, cervical spine; without contrast material |
7,372 |
7,173 |
$1.38M |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
49,534 |
48,758 |
$1.28M |
| 95811 |
|
1,838 |
1,811 |
$1.23M |
| 27447 |
|
207 |
204 |
$1.20M |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
12,191 |
11,686 |
$1.11M |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
46,023 |
44,192 |
$1.11M |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
43,167 |
34,095 |
$1.10M |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
11,401 |
11,168 |
$1.09M |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
6,187 |
6,045 |
$1.05M |
| 44970 |
|
346 |
339 |
$1.05M |
| 71045 |
Radiologic examination, chest; single view |
23,027 |
21,779 |
$1.02M |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
13,657 |
12,293 |
$1.02M |
| 76830 |
Ultrasound, transvaginal |
10,670 |
10,450 |
$1.02M |
| 78815 |
Positron emission tomography (PET) for limited area imaging |
1,407 |
1,387 |
$993K |
| 45385 |
Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) |
2,216 |
2,199 |
$981K |
| 80076 |
|
102,192 |
94,939 |
$972K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
3,508 |
3,459 |
$954K |
| 84484 |
|
62,864 |
50,967 |
$943K |
| 59025 |
Fetal non-stress test |
8,866 |
6,966 |
$907K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
106,429 |
104,259 |
$901K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
9,396 |
8,944 |
$816K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
28,021 |
14,017 |
$815K |
| D3310 |
|
6,660 |
1,767 |
$805K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
3,747 |
3,673 |
$801K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
23,161 |
22,515 |
$797K |
| 73562 |
|
10,559 |
9,730 |
$774K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
5,927 |
4,305 |
$746K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
5,144 |
5,117 |
$744K |
| 81514 |
|
3,922 |
3,859 |
$724K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
5,301 |
5,189 |
$721K |
| 87481 |
|
16,796 |
16,174 |
$720K |
| D0220 |
Intraoral - periapical first radiographic image |
3,158 |
3,132 |
$716K |
| 83690 |
|
72,991 |
67,525 |
$712K |
| 36415 |
Collection of venous blood by venipuncture |
145,533 |
135,122 |
$709K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
92,689 |
86,607 |
$703K |
| D7140 |
Extraction, erupted tooth or exposed root |
4,684 |
1,672 |
$692K |
| 70496 |
|
2,454 |
2,400 |
$683K |
| 70498 |
|
2,561 |
2,506 |
$682K |
| D0230 |
Intraoral - periapical each additional radiographic image |
4,603 |
3,102 |
$643K |
| D3220 |
Therapeutic pulpotomy (excluding final restoration) - removal of pulp coronal to the dentinocemental junction |
4,620 |
1,478 |
$633K |
| 42820 |
Tonsillectomy and adenoidectomy; younger than age 12 |
352 |
351 |
$631K |
| 84439 |
|
74,590 |
72,840 |
$623K |
| 73610 |
|
7,888 |
7,506 |
$619K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
7,114 |
7,050 |
$618K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
26,534 |
26,089 |
$615K |
| 49083 |
|
1,828 |
962 |
$599K |
| D0272 |
Bitewings - two radiographic images |
4,324 |
4,286 |
$596K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
1,529 |
1,496 |
$588K |
| 70486 |
|
3,202 |
3,135 |
$582K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
2,817 |
2,737 |
$574K |
| 73030 |
|
8,201 |
7,561 |
$568K |
| D1120 |
Prophylaxis - child |
3,934 |
3,891 |
$562K |
| 73130 |
|
9,605 |
8,856 |
$547K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
2,306 |
2,273 |
$545K |
| 82075 |
|
27,870 |
23,389 |
$544K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
15,165 |
14,779 |
$533K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
52,524 |
50,023 |
$527K |
| 82728 |
|
41,477 |
40,261 |
$525K |
| 87650 |
|
25,266 |
24,168 |
$508K |
| 58571 |
|
189 |
187 |
$507K |
| 81025 |
|
54,030 |
50,799 |
$507K |
| 80061 |
Lipid panel |
42,190 |
41,618 |
$503K |
| 52356 |
|
197 |
193 |
$498K |
| 84702 |
|
28,255 |
23,603 |
$479K |
| 64493 |
|
1,046 |
1,024 |
$466K |
| 87505 |
|
3,210 |
3,100 |
$463K |
| 45378 |
Colonoscopy, flexible; diagnostic, including collection of specimen(s) |
908 |
895 |
$463K |
| 70491 |
|
1,701 |
1,673 |
$462K |
| 85027 |
|
78,946 |
73,125 |
$459K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
30,287 |
29,405 |
$454K |
| D0240 |
|
2,907 |
1,485 |
$447K |
| 76801 |
|
4,419 |
4,036 |
$442K |
| 73630 |
|
8,469 |
7,957 |
$437K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
10,524 |
10,169 |
$435K |
| 96376 |
|
18,169 |
13,037 |
$434K |
| 88307 |
|
3,570 |
3,468 |
$433K |
| 86780 |
|
32,466 |
31,925 |
$432K |
| 72100 |
|
6,062 |
5,937 |
$426K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
2,037 |
2,016 |
$416K |
| 86803 |
|
30,230 |
29,713 |
$405K |
| J1745 |
Injection, infliximab, excludes biosimilar, 10 mg |
258 |
205 |
$401K |
| 74174 |
|
1,028 |
1,011 |
$397K |
| 93971 |
|
5,901 |
5,696 |
$390K |
| D2391 |
Resin-based composite - one surface, posterior, primary or permanent |
2,485 |
1,044 |
$387K |
| 76536 |
|
4,446 |
4,401 |
$380K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
1,197 |
1,159 |
$364K |
| 64635 |
|
464 |
456 |
$362K |
| 69436 |
Tympanostomy (requiring insertion of ventilating tube), general anesthesia |
236 |
235 |
$359K |
| 80074 |
|
8,008 |
7,844 |
$359K |
| 76770 |
|
4,158 |
4,103 |
$353K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
10,343 |
10,295 |
$328K |
| 73110 |
|
6,090 |
5,707 |
$324K |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
13,485 |
13,250 |
$324K |
| 99499 |
|
2,205 |
2,176 |
$323K |
| 87077 |
|
36,907 |
35,057 |
$322K |
| 81003 |
|
96,063 |
90,288 |
$321K |
| G0121 |
Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk |
686 |
684 |
$316K |
| 97162 |
|
8,596 |
8,435 |
$313K |
| 97113 |
|
4,350 |
1,771 |
$309K |
| G0399 |
Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation |
1,760 |
1,749 |
$302K |
| 77385 |
|
886 |
84 |
$300K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
5,170 |
4,990 |
$296K |
| 87653 |
|
8,506 |
8,370 |
$292K |
| 83880 |
|
12,409 |
11,717 |
$291K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
6,778 |
4,564 |
$290K |
| 83605 |
|
20,163 |
17,981 |
$287K |
| D1206 |
Topical application of fluoride varnish |
3,151 |
3,113 |
$283K |
| 76870 |
|
3,014 |
2,911 |
$282K |
| 83550 |
|
33,810 |
32,905 |
$275K |
| 43235 |
|
610 |
603 |
$269K |
| 30140 |
|
181 |
178 |
$261K |
| 72141 |
|
1,001 |
989 |
$258K |
| 82607 |
|
20,002 |
19,619 |
$257K |
| 74018 |
|
4,621 |
4,421 |
$257K |
| 95782 |
|
299 |
298 |
$257K |
| 86480 |
|
4,367 |
4,277 |
$255K |
| 74183 |
|
603 |
599 |
$254K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
3,771 |
3,456 |
$254K |
| D3330 |
Endodontic therapy, molar tooth (excluding final restoration) |
2,193 |
831 |
$253K |
| 74178 |
|
1,054 |
1,045 |
$252K |
| 87186 |
|
28,704 |
27,340 |
$250K |
| 93970 |
|
2,400 |
2,341 |
$250K |
| 81001 |
|
57,769 |
54,058 |
$247K |
| 88342 |
|
5,347 |
5,191 |
$247K |
| 72158 |
|
575 |
564 |
$230K |
| 86235 |
|
2,993 |
2,913 |
$228K |
| 12001 |
|
2,456 |
2,411 |
$225K |
| J0585 |
Injection, onabotulinumtoxina, 1 unit |
807 |
426 |
$220K |
| 86850 |
|
23,295 |
22,030 |
$218K |
| 71250 |
|
1,781 |
1,753 |
$218K |
| 73080 |
|
3,880 |
3,681 |
$211K |
| 83540 |
|
34,526 |
33,589 |
$206K |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
34,721 |
31,493 |
$203K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
5,945 |
4,480 |
$203K |
| 86923 |
|
1,400 |
1,169 |
$202K |
| J0561 |
Injection, penicillin g benzathine, 100,000 units |
1,767 |
1,729 |
$201K |
| 64636 |
|
816 |
451 |
$199K |
| 83970 |
|
5,831 |
5,595 |
$198K |
| 72040 |
|
2,712 |
2,663 |
$198K |
| 64490 |
|
449 |
440 |
$193K |
| 83516 |
|
8,954 |
7,905 |
$192K |
| J0897 |
Injection, denosumab, 1 mg |
523 |
517 |
$191K |
| 87040 |
|
10,025 |
6,903 |
$190K |
| 84703 |
|
20,745 |
19,902 |
$189K |
| 87340 |
|
19,037 |
18,710 |
$189K |
| 36430 |
|
1,028 |
709 |
$188K |
| 47563 |
|
75 |
74 |
$185K |
| 95813 |
|
990 |
988 |
$185K |
| 72131 |
|
1,181 |
1,161 |
$184K |
| 87522 |
Neg quan hep c or qual rna |
4,406 |
4,226 |
$184K |
| 82746 |
|
14,377 |
14,122 |
$181K |
| 70487 |
|
591 |
584 |
$175K |
| 29125 |
|
1,607 |
1,567 |
$174K |
| 71101 |
|
2,444 |
2,378 |
$172K |
| 82962 |
|
35,118 |
21,138 |
$172K |
| 86140 |
|
38,515 |
37,111 |
$169K |
| 99222 |
Initial hospital care, per day, moderate complexity |
1,204 |
1,176 |
$167K |
| 83735 |
|
25,971 |
21,164 |
$165K |
| 77301 |
|
252 |
245 |
$162K |
| 84403 |
|
6,520 |
6,295 |
$161K |
| 72070 |
|
2,226 |
2,177 |
$160K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
7,155 |
6,964 |
$156K |
| 77386 |
|
430 |
49 |
$156K |
| 95819 |
|
1,055 |
1,043 |
$156K |
| 73502 |
|
4,184 |
3,976 |
$155K |
| 73090 |
|
2,714 |
2,554 |
$154K |
| 86762 |
|
10,907 |
10,741 |
$153K |
| Q5119 |
Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg |
73 |
50 |
$153K |
| 10005 |
|
266 |
260 |
$151K |
| 73590 |
|
2,917 |
2,738 |
$150K |
| 10060 |
|
1,849 |
1,793 |
$150K |
| 73221 |
|
521 |
500 |
$150K |
| J1750 |
Injection, iron dextran, 50 mg |
624 |
562 |
$148K |
| 84112 |
|
1,856 |
1,530 |
$148K |
| 85379 |
|
12,897 |
12,511 |
$146K |
| 86038 |
|
12,767 |
12,516 |
$144K |
| 12011 |
|
1,444 |
1,431 |
$140K |
| 82805 |
|
3,335 |
2,946 |
$139K |
| 96367 |
|
3,434 |
2,559 |
$139K |
| 78264 |
|
601 |
597 |
$139K |
| 58661 |
|
51 |
51 |
$138K |
| 87902 |
|
537 |
516 |
$138K |
| J1439 |
Injection, ferric carboxymaltose, 1 mg |
240 |
152 |
$138K |
| 85610 |
|
36,811 |
31,590 |
$138K |
| 74019 |
|
1,380 |
1,348 |
$136K |
| 87660 |
|
7,018 |
6,678 |
$136K |
| 82570 |
|
30,373 |
28,937 |
$136K |
| 87510 |
|
7,004 |
6,667 |
$136K |
| 87480 |
|
7,017 |
6,676 |
$135K |
| P9047 |
Infusion, albumin (human), 25%, 50 ml |
832 |
405 |
$135K |
| 20610 |
|
1,819 |
1,608 |
$134K |
| 86787 |
|
10,578 |
10,445 |
$133K |
| J3490 |
Unclassified drugs |
129,865 |
41,206 |
$131K |
| 12002 |
|
1,487 |
1,458 |
$130K |
| 88185 |
|
548 |
499 |
$130K |
| 73700 |
|
769 |
750 |
$128K |
| 74022 |
|
1,479 |
1,454 |
$127K |
| 82784 |
|
12,866 |
12,442 |
$126K |
| M0243 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring |
321 |
320 |
$124K |
| 43249 |
|
353 |
349 |
$119K |
| 77336 |
|
1,532 |
682 |
$116K |
| 86900 |
|
25,383 |
23,860 |
$114K |
| D2330 |
|
933 |
531 |
$112K |
| 0225U |
|
288 |
280 |
$110K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
2,232 |
1,258 |
$110K |
| 82043 |
|
22,023 |
21,549 |
$108K |
| 36000 |
|
17,718 |
17,025 |
$107K |
| 82077 |
|
9,431 |
8,697 |
$107K |
| 97163 |
|
1,892 |
1,863 |
$105K |
| 78227 |
|
397 |
391 |
$104K |
| 87632 |
|
470 |
444 |
$103K |
| 80047 |
|
9,375 |
9,021 |
$103K |
| 84153 |
|
6,434 |
6,267 |
$103K |
| 93017 |
|
830 |
802 |
$103K |
| D1351 |
Sealant - per tooth |
888 |
310 |
$103K |
| 85652 |
|
33,452 |
32,347 |
$100K |
| 86160 |
|
4,754 |
4,286 |
$98K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
2,275 |
2,250 |
$98K |
| 83001 |
|
5,188 |
5,121 |
$96K |
| D2331 |
|
823 |
443 |
$95K |
| 82670 |
|
3,323 |
3,285 |
$93K |
| 84270 |
|
4,398 |
4,260 |
$92K |
| 29581 |
|
1,304 |
567 |
$90K |
| 90715 |
|
5,997 |
5,881 |
$89K |
| 88341 |
|
747 |
719 |
$88K |
| 86901 |
|
25,308 |
23,801 |
$88K |
| 97597 |
|
1,300 |
904 |
$86K |
| 73701 |
|
302 |
294 |
$86K |
| 86376 |
|
5,973 |
5,889 |
$84K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
1,087 |
1,064 |
$80K |
| 64494 |
|
1,033 |
1,016 |
$80K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
2,181 |
2,125 |
$80K |
| 30520 |
|
78 |
76 |
$79K |
| D2392 |
Resin-based composite - two surfaces, posterior, primary or permanent |
685 |
355 |
$78K |
| J0248 |
Injection, remdesivir, 1 mg |
221 |
72 |
$78K |
| 97161 |
|
3,591 |
3,517 |
$77K |
| 87075 |
|
6,210 |
5,881 |
$77K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
779 |
755 |
$77K |
| 88304 |
|
3,429 |
3,357 |
$76K |
| 64495 |
|
984 |
965 |
$75K |
| 87070 |
|
8,063 |
7,612 |
$75K |
| 94010 |
|
677 |
666 |
$74K |
| 84146 |
|
3,775 |
3,724 |
$74K |
| 86706 |
|
7,174 |
7,022 |
$73K |
| 86704 |
|
6,463 |
6,324 |
$73K |
| G0145 |
Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision |
3,411 |
3,380 |
$73K |
| 96415 |
|
1,617 |
1,268 |
$73K |
| 87081 |
|
11,846 |
11,700 |
$71K |
| 82378 |
|
4,427 |
3,596 |
$71K |
| 83002 |
|
3,811 |
3,762 |
$70K |
| 93797 |
|
2,041 |
362 |
$69K |
| 76775 |
|
854 |
842 |
$69K |
| 82565 |
|
14,243 |
13,340 |
$69K |
| 84425 |
|
3,488 |
3,463 |
$67K |
| 84481 |
|
4,066 |
3,974 |
$66K |
| 87338 |
|
4,808 |
4,751 |
$65K |
| 73140 |
|
1,209 |
1,157 |
$65K |
| 82274 |
|
4,505 |
4,447 |
$63K |
| 62323 |
|
175 |
172 |
$62K |
| 86147 |
|
1,152 |
1,072 |
$62K |
| 85730 |
|
10,774 |
10,247 |
$61K |
| Q3014 |
Telehealth originating site facility fee |
3,924 |
3,686 |
$61K |
| 83655 |
|
4,683 |
4,658 |
$61K |
| 86200 |
|
4,811 |
4,719 |
$59K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
43,587 |
35,638 |
$58K |
| 72156 |
|
131 |
131 |
$58K |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
944 |
921 |
$58K |
| 94375 |
|
910 |
890 |
$58K |
| 51702 |
|
1,468 |
1,345 |
$57K |
| 77300 |
|
326 |
311 |
$56K |
| 73522 |
|
1,015 |
995 |
$56K |
| 87529 |
|
1,531 |
1,505 |
$56K |
| 82550 |
|
9,152 |
8,507 |
$55K |
| 73060 |
|
1,097 |
1,052 |
$55K |
| 77014 |
|
1,878 |
188 |
$55K |
| 64721 |
|
56 |
56 |
$55K |
| 82248 |
|
11,060 |
8,350 |
$55K |
| C8929 |
Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography |
110 |
108 |
$55K |
| P9016 |
Red blood cells, leukocytes reduced, each unit |
299 |
253 |
$54K |
| 74240 |
|
619 |
618 |
$54K |
| 86258 |
|
4,966 |
4,921 |
$53K |
| 77338 |
|
261 |
249 |
$53K |
| 82024 |
|
1,404 |
1,378 |
$53K |
| 86146 |
|
1,019 |
960 |
$53K |
| 84305 |
|
1,901 |
1,853 |
$53K |
| 97166 |
|
1,555 |
1,530 |
$52K |
| M0245 |
Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring |
107 |
107 |
$52K |
| 86431 |
|
9,803 |
9,601 |
$52K |
| 83615 |
|
9,050 |
7,841 |
$51K |
| 86364 |
|
4,948 |
4,916 |
$51K |
| 74230 |
|
676 |
670 |
$50K |
| 51701 |
|
626 |
607 |
$50K |
| 77334 |
|
181 |
139 |
$50K |
| 77427 |
|
421 |
181 |
$50K |
| 82951 |
|
3,802 |
3,785 |
$49K |
| 82247 |
|
9,496 |
6,926 |
$48K |
| 86800 |
|
3,132 |
3,090 |
$48K |
| 36561 |
|
42 |
42 |
$48K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
183 |
176 |
$47K |
| D1510 |
|
416 |
296 |
$47K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
42,812 |
38,210 |
$47K |
| 92611 |
|
653 |
647 |
$46K |
| 86225 |
|
3,377 |
3,320 |
$46K |
| 83993 |
|
2,416 |
2,391 |
$46K |
| 36591 |
|
1,219 |
725 |
$46K |
| 82105 |
|
3,051 |
2,915 |
$45K |
| 82533 |
|
2,693 |
2,505 |
$45K |
| C1713 |
Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) |
962 |
946 |
$45K |
| 86870 |
|
253 |
228 |
$45K |
| 82803 |
|
1,780 |
1,720 |
$44K |
| 84100 |
|
9,687 |
7,303 |
$44K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
12,025 |
9,939 |
$44K |
| 29515 |
|
643 |
631 |
$43K |
| 84550 |
|
10,033 |
9,082 |
$43K |
| 72110 |
|
658 |
649 |
$43K |
| 70360 |
|
763 |
759 |
$43K |
| G0283 |
Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care |
2,920 |
1,712 |
$42K |
| 90837 |
Psychotherapy, 53 minutes with patient |
983 |
695 |
$42K |
| 86003 |
|
599 |
593 |
$41K |
| 88173 |
|
707 |
529 |
$41K |
| 73552 |
|
948 |
900 |
$40K |
| 81002 |
|
13,584 |
12,843 |
$40K |
| 86696 |
|
2,066 |
2,054 |
$40K |
| D2332 |
|
339 |
195 |
$38K |
| 88313 |
|
413 |
407 |
$38K |
| 72197 |
|
82 |
82 |
$37K |
| 76882 |
|
420 |
412 |
$37K |
| 99221 |
|
353 |
350 |
$36K |
| 84520 |
|
9,353 |
8,970 |
$35K |
| 82140 |
|
2,837 |
2,543 |
$35K |
| 86708 |
|
2,881 |
2,831 |
$34K |
| 84132 |
|
7,962 |
7,247 |
$34K |
| 74181 |
|
118 |
113 |
$34K |
| 87205 |
|
8,076 |
7,662 |
$34K |
| 72170 |
|
536 |
523 |
$33K |
| 84460 |
|
6,457 |
5,765 |
$33K |
| 82977 |
|
4,620 |
4,469 |
$33K |
| 64491 |
|
446 |
437 |
$32K |
| 64492 |
|
438 |
428 |
$32K |
| 74220 |
|
449 |
448 |
$31K |
| 86300 |
|
1,349 |
1,185 |
$31K |
| A9577 |
Injection, gadobenate dimeglumine (multihance), per ml |
5,553 |
5,394 |
$31K |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
40,759 |
31,784 |
$31K |
| 84450 |
|
6,169 |
5,477 |
$31K |
| 77412 |
|
283 |
29 |
$31K |
| M0222 |
Intravenous injection, bebtelovimab, includes injection and post administration monitoring |
100 |
100 |
$31K |
| 84145 |
|
1,916 |
1,821 |
$30K |
| 80143 |
|
2,119 |
1,960 |
$30K |
| 72114 |
|
554 |
542 |
$29K |
| 52332 |
|
14 |
14 |
$29K |
| 82330 |
|
2,612 |
2,087 |
$29K |
| 84295 |
|
6,214 |
5,849 |
$29K |
| 80179 |
|
2,049 |
1,903 |
$29K |
| 88184 |
|
550 |
520 |
$29K |
| 84156 |
|
8,349 |
7,485 |
$28K |
| 82435 |
|
6,063 |
5,727 |
$28K |
| 83525 |
|
2,394 |
2,359 |
$28K |
| 82947 |
|
6,707 |
6,364 |
$28K |
| 87210 |
|
4,775 |
4,633 |
$28K |
| A6210 |
Foam dressing, wound cover, sterile, pad size more than 16 sq. in. but less than or equal to 48 sq. in., without adhesive border, each dressing |
1,424 |
880 |
$27K |
| 86255 |
|
1,482 |
1,376 |
$27K |
| 85060 |
|
1,233 |
1,202 |
$27K |
| C1769 |
Guide wire |
2,884 |
2,736 |
$27K |
| 94060 |
|
341 |
338 |
$27K |
| G0105 |
Colorectal cancer screening; colonoscopy on individual at high risk |
59 |
59 |
$27K |
| 10022 |
|
88 |
88 |
$27K |
| 86695 |
|
2,030 |
2,019 |
$27K |
| 82731 |
|
389 |
370 |
$27K |
| 83498 |
|
963 |
956 |
$27K |
| 82950 |
|
5,525 |
5,466 |
$26K |
| 95812 |
|
161 |
159 |
$26K |
| 95816 |
|
203 |
198 |
$26K |
| 83521 |
|
1,178 |
996 |
$26K |
| J2560 |
Injection, phenobarbital sodium, up to 120 mg |
1,460 |
1,077 |
$26K |
| J2469 |
Injection, palonosetron hcl, 25 mcg |
412 |
262 |
$26K |
| 97165 |
|
1,203 |
1,172 |
$26K |
| 97150 |
Therapeutic procedure(s), group (2 or more individuals) |
1,876 |
620 |
$25K |
| 83520 |
|
1,035 |
971 |
$25K |
| 84165 |
|
2,736 |
2,633 |
$25K |
| G0257 |
Unscheduled or emergency dialysis treatment for an esrd patient in a hospital outpatient department that is not certified as an esrd facility |
118 |
42 |
$25K |
| 84144 |
|
1,196 |
1,154 |
$25K |
| 87581 |
|
707 |
700 |
$25K |
| 86039 |
|
2,312 |
2,263 |
$25K |
| 74420 |
|
191 |
184 |
$25K |
| 28285 |
|
36 |
13 |
$24K |
| 87799 |
|
631 |
566 |
$24K |
| Q0138 |
Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) |
38 |
33 |
$24K |
| 51798 |
|
1,029 |
959 |
$24K |
| 87486 |
|
694 |
687 |
$24K |
| 97016 |
|
2,035 |
833 |
$24K |
| 97802 |
|
596 |
592 |
$24K |
| 99195 |
|
394 |
349 |
$24K |
| 84480 |
|
1,742 |
1,686 |
$23K |
| 86304 |
|
1,179 |
1,024 |
$23K |
| 86381 |
|
1,023 |
1,007 |
$23K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
43,513 |
36,920 |
$22K |
| 58563 |
|
12 |
12 |
$22K |
| 82040 |
|
4,501 |
3,906 |
$22K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
19,407 |
14,897 |
$22K |
| A6250 |
Skin sealants, protectants, moisturizers, ointments, any type, any size |
3,719 |
2,118 |
$22K |
| 82103 |
|
1,654 |
1,627 |
$22K |
| 90834 |
Psychotherapy, 45 minutes with patient |
612 |
506 |
$21K |
| 97116 |
|
1,518 |
1,142 |
$21K |
| 72128 |
|
137 |
134 |
$21K |
| 90792 |
Psychiatric diagnostic evaluation with medical services |
156 |
144 |
$21K |
| 72157 |
|
45 |
42 |
$21K |
| 88312 |
|
282 |
273 |
$20K |
| 73120 |
|
317 |
252 |
$20K |
| 64633 |
|
60 |
59 |
$19K |
| 87449 |
|
1,883 |
1,820 |
$19K |
| 41899 |
Unlisted procedure, dentoalveolar structures |
165 |
165 |
$19K |
| 78262 |
|
60 |
60 |
$19K |
| Q9966 |
Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml |
3,670 |
3,435 |
$18K |
| 99215 |
Prolong outpt/office vis |
162 |
160 |
$18K |
| 82390 |
|
1,735 |
1,707 |
$18K |
| 93458 |
|
23 |
19 |
$18K |
| 73564 |
|
423 |
337 |
$18K |
| 92610 |
|
419 |
404 |
$18K |
| 94625 |
|
573 |
99 |
$18K |
| 97167 |
|
227 |
226 |
$18K |
| 43244 |
|
42 |
39 |
$17K |
| 12013 |
|
203 |
201 |
$17K |
| 82627 |
|
784 |
778 |
$17K |
| 76857 |
|
285 |
284 |
$17K |
| 85018 |
|
5,721 |
4,984 |
$17K |
| J0690 |
Injection, cefazolin sodium, 500 mg |
10,482 |
7,630 |
$17K |
| 58558 |
|
12 |
12 |
$17K |
| 82010 |
|
2,273 |
2,096 |
$16K |
| 64483 |
|
39 |
39 |
$16K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
773 |
705 |
$16K |
| 84207 |
|
600 |
599 |
$16K |
| 86665 |
|
464 |
441 |
$16K |
| 83883 |
|
1,193 |
1,165 |
$16K |
| 85046 |
|
3,290 |
3,120 |
$16K |
| 91299 |
|
113 |
113 |
$16K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
18,096 |
16,634 |
$15K |
| 72192 |
|
139 |
137 |
$15K |
| 84154 |
|
995 |
986 |
$15K |
| 99152 |
|
1,815 |
1,743 |
$15K |
| 88112 |
|
544 |
520 |
$14K |
| 73000 |
|
246 |
235 |
$14K |
| 84445 |
|
283 |
277 |
$14K |
| 92526 |
|
272 |
166 |
$14K |
| 76885 |
|
117 |
117 |
$13K |
| D2932 |
|
118 |
31 |
$13K |
| 82150 |
|
2,134 |
2,093 |
$13K |
| U0001 |
Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel |
370 |
364 |
$13K |
| 47000 |
|
24 |
24 |
$13K |
| 86334 |
|
726 |
698 |
$13K |
| 73201 |
|
40 |
40 |
$13K |
| 83721 |
|
1,370 |
1,362 |
$13K |
| 90461 |
|
489 |
264 |
$13K |
| 72052 |
|
243 |
238 |
$13K |
| 85014 |
|
4,725 |
4,037 |
$13K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
26,319 |
20,331 |
$13K |
| 29130 |
|
265 |
264 |
$13K |
| 80164 |
|
967 |
908 |
$13K |
| 84432 |
|
831 |
818 |
$12K |
| 97535 |
Self-care/home management training, each 15 minutes |
643 |
536 |
$12K |
| 77072 |
|
120 |
119 |
$12K |
| 86015 |
|
1,202 |
1,193 |
$12K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
432 |
428 |
$12K |
| 86256 |
|
1,042 |
1,030 |
$12K |
| 84681 |
|
578 |
561 |
$12K |
| 86694 |
|
799 |
788 |
$12K |
| Q5121 |
Injection, infliximab-axxq, biosimilar, (avsola), 10 mg |
630 |
405 |
$11K |
| 70481 |
|
40 |
39 |
$11K |
| 78306 |
|
59 |
59 |
$11K |
| J2704 |
Injection, propofol, 10 mg |
19,488 |
17,723 |
$11K |
| 90833 |
Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) |
1,505 |
1,449 |
$11K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
208 |
115 |
$11K |
| 72081 |
|
146 |
146 |
$11K |
| 94726 |
|
184 |
184 |
$11K |
| 82397 |
|
786 |
781 |
$11K |
| 99233 |
Prolong inpt eval add15 m |
126 |
81 |
$11K |
| D1208 |
Topical application of fluoride, excluding varnish |
83 |
82 |
$11K |
| 87634 |
|
168 |
167 |
$11K |
| 85613 |
|
1,035 |
1,020 |
$10K |
| 64634 |
|
62 |
58 |
$10K |
| 93296 |
|
882 |
865 |
$9K |
| G0239 |
Therapeutic procedures to improve respiratory function or increase strength or endurance of respiratory muscles, two or more individuals (includes monitoring) |
461 |
77 |
$9K |
| 86308 |
|
1,389 |
1,373 |
$9K |
| 80177 |
|
799 |
759 |
$9K |
| 64615 |
|
123 |
120 |
$9K |
| Q0091 |
Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory |
658 |
630 |
$9K |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
3,731 |
2,101 |
$9K |
| 96401 |
|
376 |
274 |
$9K |
| 82985 |
|
632 |
628 |
$9K |
| C1776 |
Joint device (implantable) |
543 |
537 |
$9K |
| 62270 |
|
44 |
40 |
$9K |
| J2785 |
Injection, regadenoson, 0.1 mg |
126 |
122 |
$8K |
| 73560 |
|
235 |
223 |
$8K |
| D2390 |
|
77 |
26 |
$8K |
| 97035 |
|
689 |
441 |
$8K |
| J2360 |
Injection, orphenadrine citrate, up to 60 mg |
1,607 |
1,563 |
$8K |
| 87324 |
|
676 |
655 |
$8K |
| 10061 |
|
75 |
73 |
$8K |
| J3370 |
Injection, vancomycin hcl, 500 mg |
1,266 |
830 |
$8K |
| 72146 |
|
30 |
29 |
$8K |
| 87328 |
|
608 |
584 |
$8K |
| 73200 |
|
47 |
46 |
$7K |
| J1790 |
Injection, droperidol, up to 5 mg |
3,003 |
2,831 |
$7K |
| 94729 |
|
238 |
236 |
$7K |
| A6212 |
Foam dressing, wound cover, sterile, pad size 16 sq. in. or less, with any size adhesive border, each dressing |
659 |
482 |
$7K |
| C1725 |
Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability) |
313 |
300 |
$7K |
| 90670 |
|
712 |
680 |
$7K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
10,509 |
9,242 |
$7K |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
2,905 |
2,795 |
$7K |
| 86301 |
|
415 |
342 |
$7K |
| 77263 |
|
62 |
62 |
$7K |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
10,221 |
8,740 |
$7K |
| 94644 |
|
71 |
67 |
$7K |
| 72220 |
|
144 |
141 |
$7K |
| J2060 |
Injection, lorazepam, 2 mg |
5,921 |
4,990 |
$7K |
| 90832 |
Psychotherapy, 30 minutes with patient |
210 |
175 |
$7K |
| 89051 |
|
1,017 |
785 |
$6K |
| 52000 |
|
39 |
39 |
$6K |
| 86664 |
|
400 |
399 |
$6K |
| 80197 |
|
888 |
445 |
$6K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
4,926 |
4,697 |
$6K |
| 82653 |
|
308 |
307 |
$6K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
14,143 |
13,117 |
$6K |
| 74450 |
|
36 |
36 |
$5K |
| 86663 |
|
400 |
399 |
$5K |
| 90686 |
|
1,112 |
1,092 |
$5K |
| J3411 |
Injection, thiamine hcl, 100 mg |
1,721 |
1,099 |
$5K |
| 90732 |
|
218 |
207 |
$5K |
| 97760 |
|
129 |
115 |
$5K |
| 72193 |
|
13 |
13 |
$5K |
| C1894 |
Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser |
784 |
763 |
$5K |
| J0295 |
Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm |
1,358 |
674 |
$5K |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
2,401 |
2,023 |
$5K |
| M0247 |
Intravenous infusion, sotrovimab, includes infusion and post administration monitoring |
15 |
15 |
$5K |
| 73100 |
|
101 |
89 |
$5K |
| 99231 |
Subsequent hospital care, per day, straightforward or low complexity |
98 |
80 |
$5K |
| 82525 |
|
413 |
404 |
$5K |
| J3480 |
Injection, potassium chloride, per 2 meq |
1,776 |
1,209 |
$5K |
| A6196 |
Alginate or other fiber gelling dressing, wound cover, sterile, pad size 16 sq. in. or less, each dressing |
538 |
346 |
$5K |
| G0260 |
Injection procedure for sacroiliac joint; provision of anesthetic, steroid and/or other therapeutic agent, with or without arthrography |
13 |
13 |
$5K |
| 80178 |
|
640 |
591 |
$5K |
| 74241 |
|
59 |
59 |
$5K |
| G0481 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed |
69 |
69 |
$5K |
| J1815 |
Injection, insulin, per 5 units |
5,691 |
2,624 |
$4K |
| A9500 |
Technetium tc-99m sestamibi, diagnostic, per study dose |
312 |
300 |
$4K |
| 99153 |
Mod sedat endo service >5yrs |
1,165 |
1,133 |
$4K |
| 62321 |
|
13 |
12 |
$4K |
| 93303 |
Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study |
13 |
12 |
$4K |
| 73620 |
|
106 |
93 |
$4K |
| 87506 |
|
18 |
18 |
$4K |
| 45381 |
|
13 |
13 |
$4K |
| J1644 |
Injection, heparin sodium, per 1000 units |
4,387 |
2,291 |
$4K |
| 97012 |
|
298 |
166 |
$4K |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
1,933 |
1,666 |
$4K |
| 82952 |
|
1,025 |
1,022 |
$4K |
| 75574 |
|
13 |
13 |
$4K |
| 76380 |
|
79 |
79 |
$4K |
| 96368 |
|
287 |
234 |
$4K |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
2,739 |
2,263 |
$4K |
| 87088 |
|
609 |
585 |
$4K |
| 93798 |
|
115 |
56 |
$4K |
| J2710 |
Injection, neostigmine methylsulfate, up to 0.5 mg |
2,289 |
2,212 |
$4K |
| C1781 |
Mesh (implantable) |
501 |
497 |
$4K |
| Q9957 |
Injection, perflutren lipid microspheres, per ml |
311 |
306 |
$4K |
| J2506 |
Injection, pegfilgrastim, excludes biosimilar, 0.5 mg |
17 |
12 |
$4K |
| 77470 |
|
13 |
13 |
$4K |
| 29105 |
|
56 |
55 |
$4K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
5,079 |
3,928 |
$4K |
| 96417 |
|
92 |
65 |
$3K |
| 64450 |
|
14 |
14 |
$3K |
| 76098 |
|
12 |
12 |
$3K |
| 88300 |
|
292 |
290 |
$3K |
| 86060 |
|
449 |
445 |
$3K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
41 |
39 |
$3K |
| 85246 |
|
122 |
120 |
$3K |
| 69209 |
|
108 |
103 |
$3K |
| 83921 |
|
167 |
167 |
$3K |
| 86593 |
|
663 |
651 |
$3K |
| 85245 |
|
118 |
115 |
$3K |
| 84436 |
|
431 |
424 |
$3K |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
4,916 |
3,758 |
$3K |
| 97018 |
|
563 |
278 |
$3K |
| 85045 |
|
621 |
573 |
$3K |
| 73600 |
|
39 |
31 |
$3K |
| D3320 |
|
24 |
15 |
$3K |
| 94681 |
|
30 |
28 |
$3K |
| A9517 |
Iodine i-131 sodium iodide capsule(s), therapeutic, per millicurie |
12 |
12 |
$3K |
| T1017 |
Targeted case management, each 15 minutes |
12 |
12 |
$3K |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
4,300 |
3,979 |
$3K |
| 93990 |
|
74 |
72 |
$3K |
| 76080 |
|
18 |
12 |
$3K |
| 80069 |
|
418 |
340 |
$3K |
| 82310 |
|
532 |
511 |
$2K |
| G0103 |
Prostate cancer screening; prostate specific antigen test (psa) |
429 |
428 |
$2K |
| 82785 |
|
140 |
140 |
$2K |
| 87147 |
|
454 |
446 |
$2K |
| 87015 |
|
329 |
305 |
$2K |
| J0171 |
Injection, adrenalin, epinephrine, 0.1 mg |
245 |
231 |
$2K |
| 86036 |
|
229 |
228 |
$2K |
| 71111 |
|
25 |
25 |
$2K |
| 84134 |
|
146 |
145 |
$2K |
| G0008 |
Administration of influenza virus vaccine |
1,768 |
1,713 |
$2K |
| 93325 |
|
354 |
322 |
$2K |
| J1630 |
Injection, haloperidol, up to 5 mg |
2,058 |
1,900 |
$2K |
| 85390 |
|
123 |
118 |
$2K |
| 84238 |
|
49 |
43 |
$2K |
| 88302 |
|
92 |
91 |
$2K |
| J2543 |
Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) |
833 |
408 |
$2K |
| 88344 |
|
14 |
13 |
$2K |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
2,437 |
1,113 |
$2K |
| 84155 |
|
586 |
571 |
$2K |
| 93880 |
|
40 |
39 |
$2K |
| 91320 |
|
194 |
194 |
$2K |
| 71100 |
|
40 |
40 |
$2K |
| 36416 |
|
782 |
702 |
$2K |
| 70480 |
|
13 |
13 |
$2K |
| C1726 |
Catheter, balloon dilatation, non-vascular |
377 |
371 |
$2K |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
1,529 |
1,467 |
$2K |
| Q9969 |
Tc-99m from non-highly enriched uranium source, full cost recovery add-on, per study dose |
1,262 |
1,223 |
$2K |
| 80175 |
|
144 |
140 |
$2K |
| 85240 |
|
83 |
83 |
$2K |
| A6253 |
Specialty absorptive dressing, wound cover, sterile, pad size more than 48 sq. in., without adhesive border, each dressing |
1,454 |
792 |
$2K |
| 76942 |
|
258 |
252 |
$2K |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
1,771 |
1,729 |
$2K |
| C1729 |
Catheter, drainage |
2,054 |
1,300 |
$2K |
| 88311 |
|
285 |
258 |
$2K |
| 80185 |
|
117 |
97 |
$2K |
| 87209 |
|
97 |
95 |
$2K |
| C1751 |
Catheter, infusion, inserted peripherally, centrally or midline (other than hemodialysis) |
54 |
51 |
$2K |
| 73660 |
|
36 |
36 |
$2K |
| J1953 |
Injection, levetiracetam, 10 mg |
500 |
406 |
$2K |
| 95992 |
|
17 |
12 |
$1K |
| 82365 |
|
132 |
129 |
$1K |
| J8540 |
Dexamethasone, oral, 0.25 mg |
709 |
612 |
$1K |
| S0028 |
Injection, famotidine, 20 mg |
1,049 |
945 |
$1K |
| 82668 |
|
84 |
83 |
$1K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
18 |
12 |
$1K |
| J2359 |
Injection, olanzapine, 0.5 mg |
82 |
71 |
$1K |
| J0500 |
Injection, dicyclomine hcl, up to 20 mg |
537 |
490 |
$1K |
| 64447 |
|
13 |
13 |
$1K |
| 81050 |
|
388 |
376 |
$1K |
| J0475 |
Injection, baclofen, 10 mg |
154 |
96 |
$1K |
| 76937 |
|
293 |
282 |
$1K |
| 99157 |
|
308 |
306 |
$1K |
| J3360 |
Injection, diazepam, up to 5 mg |
134 |
122 |
$1K |
| 84157 |
|
239 |
216 |
$1K |
| 82157 |
|
41 |
41 |
$1K |
| 85384 |
|
124 |
123 |
$1K |
| 91065 |
|
12 |
12 |
$1K |
| J0360 |
Injection, hydralazine hcl, up to 20 mg |
732 |
627 |
$1K |
| 80050 |
General health panel |
51 |
51 |
$1K |
| C2617 |
Stent, non-coronary, temporary, without delivery system |
342 |
332 |
$1K |
| 82375 |
|
67 |
64 |
$1K |
| 90656 |
|
243 |
243 |
$1K |
| Q0177 |
Hydroxyzine pamoate, 25 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
2,604 |
2,177 |
$990.96 |
| J1756 |
Injection, iron sucrose, 1 mg |
201 |
105 |
$973.27 |
| 82652 |
|
29 |
29 |
$938.16 |
| 87102 |
|
119 |
117 |
$907.66 |
| 87177 |
|
96 |
94 |
$860.14 |
| 17250 |
|
165 |
122 |
$830.94 |
| 97168 |
|
15 |
15 |
$825.16 |
| 85347 |
|
81 |
53 |
$819.45 |
| 70160 |
|
12 |
12 |
$805.82 |
| 86341 |
|
27 |
24 |
$798.78 |
| 93320 |
|
75 |
69 |
$794.00 |
| 86765 |
|
61 |
55 |
$770.59 |
| J0735 |
Injection, clonidine hydrochloride, 1 mg |
756 |
637 |
$760.04 |
| A6206 |
Contact layer, sterile, 16 sq. in. or less, each dressing |
110 |
60 |
$759.75 |
| 86735 |
|
58 |
53 |
$753.00 |
| 85130 |
|
67 |
65 |
$740.05 |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
522 |
503 |
$738.50 |
| 72050 |
|
12 |
12 |
$736.50 |
| S9083 |
Global fee urgent care centers |
53,854 |
51,092 |
$725.07 |
| C1887 |
Catheter, guiding (may include infusion/perfusion capability) |
191 |
183 |
$713.03 |
| 30901 |
|
13 |
12 |
$700.64 |
| J7060 |
5% dextrose/water (500 ml = 1 unit) |
822 |
601 |
$692.86 |
| 73070 |
|
13 |
12 |
$687.08 |
| 76010 |
|
13 |
13 |
$682.40 |
| J1940 |
Injection, furosemide, up to 20 mg |
1,072 |
815 |
$664.41 |
| 87329 |
|
53 |
52 |
$654.24 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
674 |
585 |
$652.02 |
| A6261 |
Wound filler, gel/paste, per fluid ounce, not otherwise specified |
406 |
267 |
$649.65 |
| 82088 |
|
15 |
14 |
$639.12 |
| G0009 |
Administration of pneumococcal vaccine |
548 |
522 |
$637.11 |
| J2371 |
Injection, phenylephrine hydrochloride, 20 micrograms |
1,450 |
1,277 |
$616.88 |
| 93926 |
|
12 |
12 |
$616.05 |
| 82945 |
|
125 |
116 |
$615.97 |
| J2370 |
Injection, phenylephrine hcl, up to 1 ml |
2,127 |
1,861 |
$593.44 |
| J3489 |
Injection, zoledronic acid, 1 mg |
37 |
37 |
$581.30 |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
92 |
92 |
$567.91 |
| 80321 |
|
381 |
369 |
$564.50 |
| J1836 |
Injection, metronidazole, 10 mg |
808 |
506 |
$559.01 |
| 84080 |
|
41 |
41 |
$558.68 |
| J2310 |
Injection, naloxone hydrochloride, per 1 mg |
61 |
52 |
$520.22 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
12 |
12 |
$513.52 |
| 87641 |
|
12 |
12 |
$509.06 |
| A6211 |
Foam dressing, wound cover, sterile, pad size more than 48 sq. in., without adhesive border, each dressing |
14 |
12 |
$501.90 |
| A9537 |
Technetium tc-99m mebrofenin, diagnostic, per study dose, up to 15 millicuries |
368 |
361 |
$487.09 |
| 83020 |
|
34 |
33 |
$486.75 |
| 86769 |
|
13 |
13 |
$479.43 |
| 84075 |
|
93 |
88 |
$468.95 |
| 84478 |
|
96 |
96 |
$464.13 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
828 |
802 |
$452.63 |
| G0452 |
Molecular pathology procedure; physician interpretation and report |
33 |
30 |
$446.21 |
| 80361 |
|
930 |
911 |
$446.06 |
| 94760 |
|
47 |
37 |
$437.75 |
| 90480 |
|
194 |
194 |
$434.88 |
| J0744 |
Injection, ciprofloxacin for intravenous infusion, 200 mg |
302 |
222 |
$425.74 |
| J2920 |
Injection, methylprednisolone sodium succinate, up to 40 mg |
221 |
166 |
$417.25 |
| S9443 |
Lactation classes, non-physician provider, per session |
125 |
106 |
$415.00 |
| 82104 |
|
26 |
25 |
$391.51 |
| 82085 |
|
40 |
38 |
$386.04 |
| J1817 |
Insulin for administration through dme (i.e., insulin pump) per 50 units |
265 |
144 |
$384.52 |
| A6262 |
Wound filler, dry form, per gram, not otherwise specified |
448 |
319 |
$379.30 |
| 84466 |
|
28 |
28 |
$373.97 |
| 90785 |
|
238 |
225 |
$348.56 |
| 84244 |
|
15 |
15 |
$344.97 |
| J2795 |
Injection, ropivacaine hydrochloride, 1 mg |
902 |
719 |
$327.85 |
| A9552 |
Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries |
1,221 |
1,207 |
$318.54 |
| 82657 |
|
16 |
16 |
$302.04 |
| 80325 |
|
141 |
141 |
$294.19 |
| A6260 |
Wound cleansers, any type, any size |
298 |
227 |
$278.24 |
| 93246 |
|
12 |
12 |
$277.97 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
116 |
95 |
$275.81 |
| Q2038 |
Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluzone) |
185 |
180 |
$272.65 |
| 93242 |
|
13 |
12 |
$272.61 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
57 |
50 |
$268.83 |
| 87176 |
|
89 |
84 |
$266.26 |
| 97039 |
|
20 |
13 |
$265.08 |
| 69210 |
|
12 |
12 |
$258.13 |
| 0141U |
|
121 |
120 |
$251.61 |
| A9541 |
Technetium tc-99m sulfur colloid, diagnostic, per study dose, up to 20 millicuries |
559 |
553 |
$250.52 |
| 80365 |
|
935 |
916 |
$249.70 |
| 94761 |
|
74 |
74 |
$233.09 |
| 90651 |
|
29 |
29 |
$224.74 |
| A6209 |
Foam dressing, wound cover, sterile, pad size 16 sq. in. or less, without adhesive border, each dressing |
32 |
26 |
$222.20 |
| 80356 |
|
952 |
933 |
$220.49 |
| J0137 |
Injection, acetaminophen (hikma), not therapeutically equivalent to j0131, 10 mg |
410 |
407 |
$213.12 |
| 82175 |
|
13 |
13 |
$211.57 |
| J0612 |
Injection, calcium gluconate, not otherwise specified, 10 mg |
188 |
116 |
$211.39 |
| G8978 |
Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals |
687 |
648 |
$197.63 |
| 84376 |
|
32 |
32 |
$188.76 |
| 83825 |
|
13 |
13 |
$188.58 |
| 83835 |
|
13 |
12 |
$164.94 |
| 80165 |
|
12 |
12 |
$162.10 |
| 99406 |
|
146 |
135 |
$155.34 |
| 84630 |
|
13 |
13 |
$153.56 |
| 89060 |
|
27 |
27 |
$144.24 |
| A9579 |
Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml |
107 |
106 |
$141.38 |
| 86709 |
|
12 |
12 |
$141.20 |
| J7510 |
Prednisolone oral, per 5 mg |
40 |
33 |
$139.16 |
| J1050 |
Injection, medroxyprogesterone acetate, 1 mg |
157 |
155 |
$134.03 |
| 74300 |
|
29 |
28 |
$125.05 |
| C1758 |
Catheter, ureteral |
178 |
172 |
$121.35 |
| 82705 |
|
25 |
25 |
$121.09 |
| A4216 |
Sterile water, saline and/or dextrose, diluent/flush, 10 ml |
107 |
87 |
$120.63 |
| 87184 |
|
15 |
13 |
$105.12 |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
295 |
256 |
$104.91 |
| 89050 |
|
29 |
27 |
$104.42 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
82 |
81 |
$103.15 |
| 49424 |
|
18 |
12 |
$99.24 |
| Q2039 |
Influenza virus vaccine, not otherwise specified |
220 |
218 |
$97.57 |
| 99151 |
|
39 |
39 |
$90.58 |
| 90756 |
|
18 |
18 |
$74.43 |
| Q0169 |
Promethazine hydrochloride, 12.5 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
310 |
290 |
$74.14 |
| Q0144 |
Azithromycin dihydrate, oral, capsules/powder, 1 gram |
33 |
30 |
$72.73 |
| 83930 |
|
12 |
12 |
$70.48 |
| 82465 |
|
17 |
17 |
$68.24 |
| Q2036 |
Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (flulaval) |
152 |
140 |
$65.58 |
| G8979 |
Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
780 |
729 |
$63.50 |
| J2175 |
Injection, meperidine hydrochloride, per 100 mg |
293 |
284 |
$62.36 |
| J0736 |
Injection, clindamycin phosphate, 300 mg |
34 |
32 |
$59.06 |
| J0610 |
Injection, calcium gluconate (fresenius kabi), per 10 ml |
46 |
25 |
$56.55 |
| C1788 |
Port, indwelling (implantable) |
40 |
40 |
$51.23 |
| 0001A |
|
327 |
325 |
$50.39 |
| J0670 |
Injection, mepivacaine hydrochloride, per 10 ml |
83 |
82 |
$48.70 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
430 |
374 |
$47.19 |
| G8985 |
Carrying, moving and handling objects, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
186 |
165 |
$46.68 |
| 81015 |
|
16 |
15 |
$44.77 |
| 90677 |
|
124 |
123 |
$41.05 |
| J7042 |
5% dextrose/normal saline (500 ml = 1 unit) |
64 |
51 |
$40.62 |
| 0124A |
|
45 |
36 |
$40.10 |
| J0456 |
Injection, azithromycin, 500 mg |
56 |
45 |
$37.72 |
| 99155 |
|
15 |
15 |
$32.01 |
| J2805 |
Injection, sincalide, 5 micrograms |
38 |
38 |
$30.53 |
| J1596 |
Injection, glycopyrrolate, 0.1 mg |
339 |
335 |
$26.29 |
| 51610 |
|
24 |
24 |
$25.55 |
| A4452 |
Tape, waterproof, per 18 square inches |
645 |
494 |
$18.66 |
| J2004 |
Injection, lidocaine hcl with epinephrine, 1 mg |
129 |
129 |
$14.31 |
| A9503 |
Technetium tc-99m medronate, diagnostic, per study dose, up to 30 millicuries |
73 |
73 |
$13.54 |
| C2625 |
Stent, non-coronary, temporary, with delivery system |
14 |
13 |
$8.66 |
| 77001 |
|
118 |
116 |
$4.67 |
| 96377 |
|
17 |
13 |
$3.45 |
| 90662 |
|
104 |
103 |
$1.01 |
| G8997 |
Swallowing functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
120 |
112 |
$0.01 |
| G8996 |
Swallowing functional limitation, current status at therapy episode outset and at reporting intervals |
119 |
110 |
$0.01 |
| 90633 |
|
12 |
12 |
$0.00 |
| 0002A |
|
263 |
263 |
$0.00 |
| G8984 |
Carrying, moving & handling objects functional limitation, current status, at therapy episode outset and at reporting intervals |
112 |
104 |
$0.00 |
| 80346 |
|
52 |
52 |
$0.00 |
| 97799 |
|
20 |
13 |
$0.00 |
| A9153 |
Multiple vitamins, with or without minerals and trace elements, oral, per dose, not otherwise specified |
19 |
14 |
$0.00 |
| 37253 |
|
15 |
14 |
$0.00 |
| C1760 |
Closure device, vascular (implantable/insertable) |
13 |
12 |
$0.00 |
| 75774 |
|
13 |
12 |
$0.00 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
90 |
74 |
$0.00 |
| A4649 |
Surgical supply; miscellaneous |
47 |
26 |
$0.00 |
| D3230 |
|
466 |
118 |
$0.00 |
| 37252 |
|
15 |
14 |
$0.00 |
| G8982 |
Changing & maintaining body position functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
19 |
16 |
$0.00 |
| G8980 |
Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting |
198 |
186 |
$0.00 |
| 0031A |
|
36 |
36 |
$0.00 |
| S2900 |
Surgical techniques requiring use of robotic surgical system (list separately in addition to code for primary procedure) |
247 |
243 |
$0.00 |
| G8981 |
Changing & maintaining body position functional limitation, current status, at therapy episode outset and at reporting intervals |
17 |
14 |
$0.00 |
| 90688 |
|
27 |
26 |
$0.00 |
| D3240 |
|
77 |
41 |
$0.00 |
| C1889 |
Implantable/insertable device, not otherwise classified |
44 |
43 |
$0.00 |
| 0011A |
|
59 |
59 |
$0.00 |
| 0134A |
|
18 |
14 |
$0.00 |
| G8998 |
Swallowing functional limitation, discharge status, at discharge from therapy or to end reporting |
14 |
13 |
$0.00 |
| 0012A |
|
20 |
20 |
$0.00 |